{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T22:10:30Z","timestamp":1785190230932,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","award":["Sanofi"],"award-info":[{"award-number":["Sanofi"]}],"id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic rhinosinusitis (inclusive of subtypes with nasal polyps [CRSwNP], without nasal polyps [CRSsNP], and allergic fungal rhinosinusitis [AFRS]) causes inflammation of the nose mucosa and paranasal sinuses. Unfortunately, evidence supporting use of clinical outcome assessments (COAs) in regulated clinical trials to assess key measurement concepts of these conditions is limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To identify key disease-related symptoms and impacts, potential outcomes of interest for new treatments, and COAs available to measure those outcomes among adult and adolescent individuals living with CRSwNP, CRSsNP, and AFRS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Literature, clinical trial, and product label reviews were conducted to identify symptoms, impacts, and COAs used to assess CRSwNP, CRSsNP, and AFRS patient experiences in clinical trials. The disease related concepts identified in the literature were mapped to selected COAs to determine conceptual coverage of each COA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-five articles, twenty-five clinical trial records, and four product labels were included in the review. Across conditions, nasal obstruction, nasal discharge, and altered smell were the most frequently identified symptoms. The most frequently identified impacts of CRSwNP and CRSsNP were on emotional functioning and sleep, and adopting new behaviors for AFRS. Findings for key symptoms and impacts in adolescents were limited. More than 20 COAs used in these conditions were identified, and 14 COAs (e.g., Sinonasal Outcome Test [SNOT-22]) were evaluated for conceptual coverage of the concepts identified in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Results specify several symptom and impact outcomes, that if improved, would reflect treatment benefit for patients living with CRSwNP, CRSsNP, and\/or AFRS. Several COAs demonstrated coverage of key measurement concepts and warrant further evaluation for use in clinical trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41687-024-00833-6","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T13:47:47Z","timestamp":1737640067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patient-centered outcomes for clinical trials in chronic rhinosinusitis with or without nasal polyps and allergic fungal rhinosinusitis"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-8982","authenticated-orcid":false,"given":"Brittany","family":"Klooster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin","family":"Chatterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazifa","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison C.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veleka","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"833_CR1","first-page":"649","volume":"6","author":"A Slovick","year":"2014","unstructured":"Slovick A, Long J, Hopkins C (2014) Updates in the management of chronic rhinosinusitis. Future Med 6:649\u2013663","journal-title":"Future Med"},{"issue":"4","key":"833_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaip.2016.03.010","volume":"4","author":"AEW Hoyt","year":"2016","unstructured":"Hoyt AEW, Borish L, Gurrola J, Payne S (2016) Allergic fungal rhinosinusitis. J Allergy Clin Immunology: Pract 4(4):599\u2013604. https:\/\/doi.org\/10.1016\/j.jaip.2016.03.010","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"29","key":"833_CR3","first-page":"1","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on Rhinosinusitis and nasal polyps. Rhinology 58(29):1\u2013464","journal-title":"Rhinology"},{"issue":"3","key":"833_CR4","first-page":"271","volume":"11","author":"D Glass","year":"2011","unstructured":"Glass D, Amedee RG (2011) Allergic fungal rhinosinusitis: a review. Ochsner J Fall 11(3):271\u2013275","journal-title":"Ochsner J Fall"},{"issue":"6","key":"833_CR5","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1945892420927244","volume":"34","author":"R Talat","year":"2020","unstructured":"Talat R, Speth MM, Gengler I et al (2020) Chronic Rhinosinusitis patients with and without polyps experience different Symptom Perception and Quality of Life burdens. Am J Rhinol Allergy Nov 34(6):742\u2013750. https:\/\/doi.org\/10.1177\/1945892420927244","journal-title":"Am J Rhinol Allergy Nov"},{"issue":"1","key":"833_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14639\/0392-100x-n1699","volume":"42","author":"M Gelardi","year":"2022","unstructured":"Gelardi M, Bocciolini C, Notargiacomo M et al (2022) Chronic rhinosinusitis with nasal polyps: how to identify eligible patients for biologics in clinical practice. Acta Otorhinolaryngol Ital Feb 42(1):75\u201381. https:\/\/doi.org\/10.14639\/0392-100x-n1699","journal-title":"Acta Otorhinolaryngol Ital Feb"},{"issue":"4","key":"833_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with Nasal Polyps. The journal of allergy and clinical immunology in practice. Jul-Aug 4(4):565\u2013572. https:\/\/doi.org\/10.1016\/j.jaip.2016.04.012","journal-title":"Jul-Aug"},{"key":"833_CR8","doi-asserted-by":"publisher","unstructured":"Bent JP 3rd, Kuhn FA (1994) Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg Nov 111(5):580\u2013588. https:\/\/doi.org\/10.1177\/019459989411100508","DOI":"10.1177\/019459989411100508"},{"key":"833_CR9","doi-asserted-by":"publisher","unstructured":"Dykewicz MS, Rodrigues JM, Slavin RG (2018) Allergic fungal rhinosinusitis. J Allergy Clin Immunol 142(2):341\u2013351. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.023","DOI":"10.1016\/j.jaci.2018.06.023"},{"issue":"6","key":"833_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jaci.2015.10.012","volume":"136","author":"L Rudmik","year":"2015","unstructured":"Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler ZM (2015) Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment. J Allergy Clin Immunol 136(6):1532\u20131540 e2","journal-title":"J Allergy Clin Immunol"},{"key":"833_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/prom.s156279","volume":"9","author":"R Mercieca-Bebber","year":"2018","unstructured":"Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M (2018) The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Measures 9:353\u2013367. https:\/\/doi.org\/10.2147\/prom.s156279","journal-title":"Patient Relat Outcome Measures"},{"key":"833_CR12","unstructured":"Agency for Healthcare Research and Quality (2012) Abstrackr: software for semi-automatic citation screening. Accessed 28 June 2024. https:\/\/effectivehealthcare.ahrq.gov\/topics\/abstractr\/abstract"},{"issue":"1","key":"833_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.1995.03520250075037","volume":"273","author":"IB Wilson","year":"1995","unstructured":"Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273(1):59\u201365","journal-title":"JAMA"},{"key":"833_CR14","unstructured":"Washington University (2006) Sino-nasal outcome test (SNOT-22). Accessed 4 May 2023. https:\/\/www.canvasc.ca\/wp-content\/uploads\/2021\/10\/SNOT22.pdf"},{"issue":"4","key":"833_CR15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, O\u2019Byrne PM, Guyatt GH, Ferrie PJ, King DR (1999) Development and validation of a questionnaire to measure asthma control. Eur Respir J 10\/1999 14(4):902\u2013907","journal-title":"Eur Respir J 10\/1999"},{"key":"833_CR16","unstructured":"University of Pennsylvania (2023) University of Pennsylvania Smell Identification Test (UPSIT). Accessed 4 May 2023. https:\/\/www.reginfo.gov\/public\/do\/DownloadDocument?objectID=25141601"},{"key":"833_CR17","unstructured":"ClinicalTrials.gov (2024) Dupilumab in CRSsNP (Liberty CRSsNP). Accessed 23 Feb 2024. https:\/\/clinicaltrials.gov\/study\/NCT04678856?cond=CRSsNP%26spons=Sanofi%26rank=1"},{"key":"833_CR18","unstructured":"ClinicalTrials.gov (2019) Controlled clinical study of Dupilumab in patients with nasal polyps (SINUS-52). Accessed 23 Feb 2024. https:\/\/clinicaltrials.gov\/study\/NCT02898454?cond=crswnp%26spons=Sanofi%26rank=2"},{"key":"833_CR19","unstructured":"ClinicalTrials.gov (2024) Dupilumab in allergic fungal rhinosinusitis (AFRS) (LIBERTY-AFRS-AI). Accessed 23 Feb 2024. https:\/\/clinicaltrials.gov\/study\/NCT04684524?cond=aFRS%26spons=Sanofi%26rank=1"},{"issue":"4","key":"833_CR20","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1749-4486.2012.02527.x","volume":"37","author":"S Abdalla","year":"2012","unstructured":"Abdalla S, Alreefy H, Hopkins C (2012) Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol Aug 37(4):276\u2013282. https:\/\/doi.org\/10.1111\/j.1749-4486.2012.02527.x","journal-title":"Clin Otolaryngol Aug"},{"issue":"12","key":"833_CR21","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/alr.21820","volume":"6","author":"JA Alt","year":"2016","unstructured":"Alt JA, Mace JC, Smith TL, Soler ZM (2016) Endoscopic sinus surgery improves cognitive dysfunction in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol Dec 6(12):1264\u20131272. https:\/\/doi.org\/10.1002\/alr.21820","journal-title":"Int Forum Allergy Rhinol Dec"},{"issue":"6","key":"833_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/02770903.2014.995308","volume":"52","author":"SE Erskine","year":"2014","unstructured":"Erskine SE, Notley C, Wilson AM, Philpott CM (2014) Managing chronic rhinosinusitis and respiratory disease: a qualitative study of triggers and interactions. J Asthma: Official J Association Care Asthma 52(6):600\u2013605. https:\/\/doi.org\/10.3109\/02770903.2014.995308","journal-title":"J Asthma: Official J Association Care Asthma"},{"issue":"7","key":"833_CR23","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.jaip.2020.04.048","volume":"8","author":"S Ghadersohi","year":"2020","unstructured":"Ghadersohi S, Price CPE, Jensen SE et al (2020) Development and preliminary validation of a new patient-reported outcome measure for chronic Rhinosinusitis (CRS-PRO). The journal of allergy and clinical immunology in practice. Jul-Aug 8(7):2341\u20132350e1. https:\/\/doi.org\/10.1016\/j.jaip.2020.04.048","journal-title":"Jul-Aug"},{"issue":"2","key":"833_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2500\/ajra.2016.30.4274","volume":"30","author":"T Greguri\u0107","year":"2016","unstructured":"Greguri\u0107 T, Trkulja V, Baudoin T, Grgi\u0107 M, \u0160migovec I, Kalogjera L (2016) Differences in the sino-nasal outcome test 22 and visual analog scale symptom scores in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol Allergy Mar-Apr 30(2):107\u2013112. https:\/\/doi.org\/10.2500\/ajra.2016.30.4274","journal-title":"Am J Rhinol Allergy Mar-Apr"},{"issue":"4","key":"833_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.12932\/ap-170818-0395","volume":"38","author":"T Hanif","year":"2020","unstructured":"Hanif T, Laulajainen-Hongisto A, Luukkainen A et al (2020) Hierarchical clustering in evaluating inflammatory upper airway phenotypes; increased symptoms in adults with allergic multimorbidity. Asian Pac J Allergy Immunol Dec 38(4):239\u2013250. https:\/\/doi.org\/10.12932\/ap-170818-0395","journal-title":"Asian Pac J Allergy Immunol Dec"},{"issue":"7","key":"833_CR26","doi-asserted-by":"publisher","first-page":"E2116","DOI":"10.1002\/lary.29280","volume":"131","author":"AC McCann","year":"2021","unstructured":"McCann AC, Trope M, Walker VL et al (2021) Olfactory dysfunction is not a determinant of patient-reported chronic Rhinosinusitis Disease Control. Laryngoscope Jul 131(7):E2116\u2013e2120. https:\/\/doi.org\/10.1002\/lary.29280","journal-title":"Laryngoscope Jul"},{"issue":"5","key":"833_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/lio2.299","volume":"4","author":"AH Nilsen","year":"2019","unstructured":"Nilsen AH, Helvik AS, Thorstensen WM, Salvesen \u00d8, Bugten V (2019) General health, vitality, and social function after sinus surgery in chronic rhinosinusitis. Laryngoscope Investig Otolaryngol Oct 4(5):476\u2013483. https:\/\/doi.org\/10.1002\/lio2.299","journal-title":"Laryngoscope Investig Otolaryngol Oct"},{"key":"833_CR28","doi-asserted-by":"publisher","unstructured":"Palmer JN, Messina JC, Biletch R, Grosel K, Mahmoud RA (2019) A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis. Allergy Asthma Proc. 40(1):48\u201356. https:\/\/doi.org\/10.2500\/aap.2019.40.4182","DOI":"10.2500\/aap.2019.40.4182"},{"issue":"5","key":"833_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/alr.21687","volume":"6","author":"CF Thompson","year":"2016","unstructured":"Thompson CF, Price CP, Huang JH et al (2016) A pilot study of symptom profiles from a polyp vs an eosinophilic-based classification of chronic rhinosinusitis. Int Forum Allergy Rhinol May 6(5):500\u2013507. https:\/\/doi.org\/10.1002\/alr.21687","journal-title":"Int Forum Allergy Rhinol May"},{"issue":"4","key":"833_CR30","doi-asserted-by":"publisher","first-page":"e022644","DOI":"10.1136\/bmjopen-2018-022644","volume":"23","author":"J Vennik","year":"2019","unstructured":"Vennik J, Eyles C, Thomas M et al (2019) Chronic rhinosinusitis: a qualitative study of patient views and experiences of current management in primary and secondary care. BMJ Open Apr 23(4):e022644. https:\/\/doi.org\/10.1136\/bmjopen-2018-022644","journal-title":"BMJ Open Apr"},{"issue":"11","key":"833_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/archotol.1997.01900110025004","volume":"123","author":"MS Benninger","year":"1997","unstructured":"Benninger MS, Senior BA (1997) The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head NeckSurg 11\/1997 123(11):1175\u20131179","journal-title":"Arch Otolaryngol Head NeckSurg 11\/1997"},{"issue":"10 Suppl","key":"833_CR32","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.apmr.2010.08.033","volume":"92","author":"JS Lai","year":"2011","unstructured":"Lai JS, Cella D, Choi S et al (2011) How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil Oct 92(10 Suppl):S20\u2013S27. https:\/\/doi.org\/10.1016\/j.apmr.2010.08.033","journal-title":"Arch Phys Med Rehabil Oct"},{"issue":"6","key":"833_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/sleep\/33.6.781","volume":"33","author":"DJ Buysse","year":"2010","unstructured":"Buysse DJ, Yu L, Moul DE et al (2010) Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep Jun 33(6):781\u2013792. https:\/\/doi.org\/10.1093\/sleep\/33.6.781","journal-title":"Sleep Jun"},{"issue":"1","key":"833_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/15402002.2012.636266","volume":"28","author":"L Yu","year":"2011","unstructured":"Yu L, Buysse DJ, Germain A et al (2011) Development of short forms from the PROMIS\u2122 sleep disturbance and sleep-related impairment item banks. Behav Sleep Med Dec 28(1):6\u201324. https:\/\/doi.org\/10.1080\/15402002.2012.636266","journal-title":"Behav Sleep Med Dec"},{"issue":"1","key":"833_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.pain.2010.04.025","volume":"150","author":"D Amtmann","year":"2010","unstructured":"Amtmann D, Cook KF, Jensen MP et al (2010) Development of a PROMIS item bank to measure pain interference. Pain Jul 150(1):173\u2013182. https:\/\/doi.org\/10.1016\/j.pain.2010.04.025","journal-title":"Pain Jul"},{"key":"833_CR36","doi-asserted-by":"publisher","unstructured":"Hahn EA, Devellis RF, Bode RK et al (2010) Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res 19(7):1035\u20131044. https:\/\/doi.org\/10.1007\/s11136-010-9654-0","DOI":"10.1007\/s11136-010-9654-0"},{"issue":"1","key":"833_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","volume":"30","author":"EF Juniper","year":"2000","unstructured":"Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (2000) Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 1\/2000 30(1):132\u2013140","journal-title":"Clin Exp Allergy 1\/2000"},{"issue":"11","key":"833_CR38","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.jaip.2021.06.037","volume":"9","author":"NJ Campion","year":"2021","unstructured":"Campion NJ, Kohler R, Ristl R, Villazala-Merino S, Eckl-Dorna J, Niederberger-Leppin V (2021) Prevalence and Symptom Burden of Nasal Polyps in a large Austrian Population. The journal of allergy and clinical immunology in practice. Nov 9(11):4117\u20134129e2. https:\/\/doi.org\/10.1016\/j.jaip.2021.06.037","journal-title":"Nov"},{"key":"833_CR39","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2147\/ppa.S320242","volume":"15","author":"AH Khan","year":"2021","unstructured":"Khan AH, Abbe A, Falissard B et al (2021) Data Mining of Free-text responses: an innovative Approach to analyzing patient perspectives on treatment for chronic rhinosinusitis with Nasal Polyps in a phase IIa proof-of-Concept Study for Dupilumab. Patient Prefer Adherence 15:2577\u20132586. https:\/\/doi.org\/10.2147\/ppa.S320242","journal-title":"Patient Prefer Adherence"},{"issue":"7","key":"833_CR40","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/all.15222","volume":"77","author":"SE Lee","year":"2022","unstructured":"Lee SE, Hopkins C, Mullol J et al (2022) Dupilumab improves health related quality of life: results from the phase 3 SINUS studies. Allergy Jul 77(7):2211\u20132221. https:\/\/doi.org\/10.1111\/all.15222","journal-title":"Allergy Jul"},{"issue":"8","key":"833_CR41","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/alr.22952","volume":"12","author":"S O\u2019Quinn","year":"2022","unstructured":"O\u2019Quinn S, Shih VH, Martin UJ et al (2022) Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary. Int Forum Allergy Rhinol Aug 12(8):996\u20131005. https:\/\/doi.org\/10.1002\/alr.22952","journal-title":"Int Forum Allergy Rhinol Aug"},{"key":"833_CR42","doi-asserted-by":"publisher","unstructured":"Peters AT, Han JK, Hellings P et al (2021) Indirect treatment comparison of biologics in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 9(6):2461\u20132471.e5. https:\/\/doi.org\/10.1016\/j.jaip.2021.01.031","DOI":"10.1016\/j.jaip.2021.01.031"},{"issue":"6","key":"833_CR43","doi-asserted-by":"publisher","first-page":"100131","DOI":"10.1016\/j.waojou.2020.100131","volume":"13","author":"Z Xu","year":"2020","unstructured":"Xu Z, Luo X, Xu L et al (2020) Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps. World Allergy Organ J Jun 13(6):100131. https:\/\/doi.org\/10.1016\/j.waojou.2020.100131","journal-title":"World Allergy Organ J Jun"},{"issue":"12","key":"833_CR44","doi-asserted-by":"publisher","first-page":"e20683","DOI":"10.7759\/cureus.20683","volume":"13","author":"AA AlAhmari","year":"2021","unstructured":"AlAhmari AA (2021) Allergic fungal rhinosinusitis in Saudi Arabia: a review of recent literature. Cureus Dec 13(12):e20683. https:\/\/doi.org\/10.7759\/cureus.20683","journal-title":"Cureus Dec"},{"issue":"4","key":"833_CR45","doi-asserted-by":"publisher","first-page":"Mc01","DOI":"10.7860\/jcdr\/2017\/23488.9610","volume":"11","author":"M Rojita","year":"2017","unstructured":"Rojita M, Samal S, Pradhan P, Venkatachalam VP (2017) Comparison of Steroid and Itraconazole for Prevention of recurrence in allergic fungal rhinosinusitis: a Randomized Controlled Trial. J Clin Diagn Res Apr 11(4):Mc01\u2013mc03. https:\/\/doi.org\/10.7860\/jcdr\/2017\/23488.9610","journal-title":"J Clin Diagn Res Apr"},{"issue":"2","key":"833_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12663-018-01182-w","volume":"18","author":"V Singh","year":"2019","unstructured":"Singh V (2019) Fungal rhinosinusitis: unravelling the Disease Spectrum. J Maxillofac Oral Surg Jun 18(2):164\u2013179. https:\/\/doi.org\/10.1007\/s12663-018-01182-w","journal-title":"J Maxillofac Oral Surg Jun"},{"issue":"6","key":"833_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/mmy\/myw125","volume":"1","author":"RK Verma","year":"2017","unstructured":"Verma RK, Patro SK, Francis AA, Panda NK, Chakrabarti A, Singh P (2017) Role of preoperative versus postoperative itraconazole in allergic fungal rhinosinusitis. Med Mycol Aug 1(6):614\u2013623. https:\/\/doi.org\/10.1093\/mmy\/myw125","journal-title":"Med Mycol Aug"},{"issue":"1","key":"833_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/lary.26778","volume":"128","author":"A Yamasaki","year":"2018","unstructured":"Yamasaki A, Hoehle LP, Phillips KM et al (2018) Association between systemic antibiotic and corticosteroid use for chronic rhinosinusitis and quality of life. Laryngoscope Jan 128(1):37\u201342. https:\/\/doi.org\/10.1002\/lary.26778","journal-title":"Laryngoscope Jan"},{"issue":"2","key":"833_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/coa.14014","volume":"48","author":"A Salil","year":"2023","unstructured":"Salil A, Joy N, Faizal B (2023) A prospective study comparing itraconazole alone versus systemic steroids alone as adjuncts to topical steroids in the post-operative management of allergic fungal rhinosinusitis. Clin Otolaryngol Mar 48(2):356\u2013362. https:\/\/doi.org\/10.1111\/coa.14014","journal-title":"Clin Otolaryngol Mar"},{"issue":"4","key":"833_CR50","doi-asserted-by":"publisher","first-page":"Cd011996","DOI":"10.1002\/14651858.CD011996.pub2","volume":"26","author":"LY Chong","year":"2016","unstructured":"Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ (2016) Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev Apr 26(4):Cd011996. https:\/\/doi.org\/10.1002\/14651858.CD011996.pub2","journal-title":"Cochrane Database Syst Rev Apr"},{"key":"833_CR51","unstructured":"Omalizumab [package insert] (2023) https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/103976Orig1s5243lbl.pdf"},{"key":"833_CR52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-020-00442-0","volume":"16","author":"DP Henriksen","year":"2020","unstructured":"Henriksen DP, Bodtger U, Sidenius K et al (2020) Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma. Allergy Asthma Clin Immunol 16:49. https:\/\/doi.org\/10.1186\/s13223-020-00442-0","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1 Suppl","key":"833_CR53","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1067\/mai.2001.115566","volume":"108","author":"EO Meltzer","year":"2001","unstructured":"Meltzer EO (2001) Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol Jul 108(1 Suppl):S45\u201353. https:\/\/doi.org\/10.1067\/mai.2001.115566","journal-title":"J Allergy Clin Immunol Jul"},{"issue":"5","key":"833_CR54","first-page":"390","volume":"18","author":"JA Linder","year":"2003","unstructured":"Linder JA, Singer DE, Ancker M, Atlas SJ (2003) Measures of health-related quality of life for adults with acute sinusitis. A systematic review. J GenIntern Med 5\/2003 18(5):390\u2013401","journal-title":"J GenIntern Med 5\/2003"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-024-00833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-024-00833-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-024-00833-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:09:00Z","timestamp":1737680940000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-024-00833-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1186\/s41687-024-00833-6","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BK, MCB, and ALS are employees of Adelphi Values; NI and KC were employees of Adelphi Values at the time of the study. Adelphi Values received payment from Sanofi to conduct the study. VA is an employee of Sanofi and may have stocks or stock options with Sanofi US Services, Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}